Yellow, viscous, oily liquid.
Dopamine receptor antagonist; neuroleptic.
Zuclopenthixol Decanoate is used in the maintenance treatment of chronic schizophrenic patients. it is one of the three distinct formulations of Zuclopenthixol namely, zuclopenthixol dihydrochloride, zuclopenthixol acetate or Acuphase and zuclopenthixol decanoate.
ChEBI: Zuclopenthixol decanoate is a member of thioxanthenes.
Long-lasting injectable formulation (depot form) of Zuclopenthixol; potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors.
Zuclopenthixol decanoate is a long-lasting injectable formulation (depot form) of Zuclopenthixol. Zuclopenthixol decanoate is a potent antagonist of D1/D2 dopamine receptors, α1-adrenergic receptors and 5-HT2 receptors. Zuclopenthixol decanoate is approved in some countries for treatment of schizophrenia and other psychoses and recommended for patients who are agitated or aggressive.
